CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
Antiseptic-coated central venous cathetersdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00413738
NCT00413738Phase 3Completed
CompareCT.gov

Prevention of Catheter-Related Bloodstream Infection in Patients With Hemato-Oncological Disease.A Randomized Controlled Trial:Heparin-Coated Central Venous Catheters Versus Antiseptic-Coated Central Venous Catheters

Centre National de Greffe de Moelle Osseuse·interventional·Posted Dec 20, 2006·Updated Jan 27, 2009

In Brief

A Phase 3 clinical trial evaluating Antiseptic-coated central venous catheters for Infection. Completed.

Detailed Summary

The aim of this prospective randomised controlled trial is to compare the incidence of catheter-related bloodstream infection in 2 groups of patients with hemato-oncological disease: Group A: heparin-coated central venous catheters (Control Group) Group B: antiseptic-coated (chlorhexidine-silver sulfadiazine) central venous catheters

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfection
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 20, 2006
Enrollment StartDec 1, 2006
Study CompletionJan 1, 2009
TodayJul 2, 2026
Posted 19.5 years ago

Interventions

Antiseptic-coated central venous cathetersdevice